Real-life practice of methotrexate toxicity monitoring in juvenile idiopathic arthritis in Germany, Switzerland and Austria: results of a cross-sectional assessment conducted in 2012.

Thumbnail
Name:
Akmatov et al.pdf
Size:
524.6Kb
Format:
PDF
Description:
original manuscript
Download
Cast your vote
 
Your vote was cast
Thank you for your feedback
Authors
Akmatov, Manas K
Stumme, Melanie
Pessler, Frank
Issue Date
2016-08-30

Metadata
Show full item record
Abstract
Methotrexate (MTX) is used at low doses to treat rheumatologic disorders in the paediatric age group. Toxicity is observed despite the low doses used. Even though recommendations for monitoring of early signs of toxicity exist in many countries, real-life practice may vary. We therefore assessed current practice in Germany, Switzerland and Austria.
Citation
Real-life practice of methotrexate toxicity monitoring in juvenile idiopathic arthritis in Germany, Switzerland and Austria: results of a cross-sectional assessment conducted in 2012., 34 (3):548-53 Clin. Exp. Rheumatol.
Affiliation
TWINCORE Centre for Experimental and Clinical Infection Research Feodor-Lynen-Str. 7 30625 Hannover, Germany.
Journal
Clinical and experimental rheumatology
URI
http://hdl.handle.net/10033/619049
PubMed ID
27156925
Type
Article
Language
en
ISSN
0392-856X
Collections

The following license files are associated with this item:

  • Creative Commons
http://creativecommons.org/licenses/by-nc-sa/4.0/
Except where otherwise noted, this item's license is described as http://creativecommons.org/licenses/by-nc-sa/4.0/